【摘要】目的 基于武汉市血液透析质量控制平台，利用其数据反馈结果，以提升武汉地区整体血磷(phosphorus , P)达标率。方法选取2018年1月～2019年1月武汉市44 家血液透析中心共3794 名血液透析患者为研究对象，利用武汉市血液透析质量控制平台的数据反馈，统计其P 的检查和达标情况，经反复评估、整改，对比1 年后P 检查和达标情况。结果①患者P、甲状旁腺激素(parathyroid hormone, PTH)水平呈降低趋势(F=11.976、10.414, P＜0.001、0.015)，血钙(calcium，Ca)水平呈升高趋势(χ2= 119.725，P＜0.001)。②患者P、Ca、PTH 的检查率不断完善，均呈上升趋势(χ2=65.994、80.834、182.306，均P＜0.001)。③患者P、Ca 的达标率呈上升趋势(χ2=32.511、10.215，P＜0.001、0.017)，血PTH达标率无明显变化(χ2=0.764，P=0.858)。结论基于平台的数据反馈，进行持续质量改进，能有效降低P 水平，提高P的检查率和达标率。
【Abstract】Objective To improve the overall serum phosphorus (P) compliance rate in Wuhan based on the data feedback from Wuhan Hemodialysis Quality Control Center platform. Methods A total of 3,794 hemodialysis patients from 44 hemodialysis centers in Wuhan in the period from January 2018 to January 2019 were selected as the research subjects. The data feedback from Wuhan Hemodialysis Quality Control Center platform were used to calculate the serum P examination and compliance rates. After repeated evaluations and renovations for one year, serum P examination and compliance rates were rEcalculated and compared with the previous rates. Results ① Serum P and parathyroid hormone (PTH) levels decreased (F=11.976 and 10.414 respectively; P<0.001 and =0.015 respectively), and serum calcium (Ca) increased (c2=119.725, P<0.001). ②The rates of serum P, Ca and PTH examinations improved and increased constantly (c2=65.994, 80.834 and 182.306 respectively, P< 0.001). ③The compliance rates of serum P and Ca increased (c2=32.511 and 10.215 respectively, P<0.001 and =0.017 respectively), but the compliance rate of PTH remained unchanged (c2=0.764, P=0.858). Conclusion Based on the data feedback from this platform and continuous quality improvement, serum P level effectively reduced and serum P examination and compliance rates increased.
[1]Bikbov B, Bieber B, Andrusev A, et al.Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS),with international comparisons[J].Hemodial Int, 2017, 21(3):393-408
[2]Brauer A, Waheed S, Singh T, et al.Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks[J].Journal of Renal Nutrition, 2019, 29(2):156-162
[3]Kong X, Zhang L, Zhang L, et al.Mineral and bone disorder in Chinese dialysis patients: a multicenter study[J].BMC Nephrol, 2012, 13:116-
[4]Yamamoto S, Karaboyas A, Komaba H, et al.Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J].BMC Nephrol, 2018, 19(1):253-
[5]Bikbov B, Bieber B, Andrusev A, et al.Hemodialysis practice patterns in the Russia Dialysis Outcomes and Practice Patterns Study (DOPPS),with international comparisons[J].Hemodial Int, 2017, 21(3):393-408
[6]Lee Y, Song D, Kim M J, et al.Upper Arm Basilic Vein Transposition for Hemodialysis: A Single Center Study for 300 Cases[J].Vasc Specialist Int, 2016, 32(2):51-56
[7]Brauer A, Waheed S, Singh T, et al.Improvement in Hyperphosphatemia Using Phosphate Education and Planning Talks[J].J Ren Nutr, 2019, 29(2):156-162
[8]Fernandez-Martin J L, Carrero J J, Benedik M, et al.COSMOS: the dialysis scenario of CKD-MBD in Europe[J].Nephrol Dial Transplant, 2013, 28(7):1922-1935
[9]Tsai W C, Yang J Y, Luan C C, et al.Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients[J].Clin Exp Nephrol, 2016, 20(5):815-821
[10]Kalantar-Zadeh K.Patient education for phosphorus management in chronic kidney disease[J].Patient Prefer Adherence, 2013, 7:379-390
[11]Browne T, Merighi J R.Barriers to adult hemodialysis patients' self-management of oral medications[J].Am J Kidney Dis, 2010, 56(3):547-557
[12]Clark S, Farrington K, Chilcot J.Nonadherence in dialysis patients: prevalence,measurement,outcome,and psychological determinants[J].Semin Dial, 2014, 27(1):42-49
[13]Cupisti A, Gallieni M, Rizzo M A, et al.Phosphate control in dialysis[J].Int J Nephrol Renovasc Dis, 2013, 6:193-205
[14]Milazi M, Bonner A, Douglas C.Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review[J].JBI Database System Rev Implement Rep, 2017, 15(4):971-1010
[15]Karavetian M, Rizk R.Patient education for hyperphosphatemia management: Improving outcomes while decreasing costs?[J].Kidney Res Clin Pract, 2018, 37(1):4-7
[16]Rizk R, Hiligsmann M, Karavetian M, et al.Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial[J].J Med Econ, 2017, 20(10):1024-1038
[17]Stumm E M, Kirchner R M, Guido L A, et al.Educational nursing intervention to reduce the hyperphosphatemia in patients on hemodialysis[J].Rev Bras Enferm, 2017, 70(1):31-38
[18]石明, 熊扬眉, 马屹茕, 等.湖北省血液透析患者质量控制数据分析[J].中国血液净化, 2018, 17(12):854-857
[19]熊飞, 闵永龙, 张燕敏, 等.年度武汉市血液透析质控调查报告[J].临床肾脏病杂志, 2017, 17(8):461-465
[20]Fernandez-Martin J L, Martinez-Camblor P, Dionisi M P, et al.Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study[J].Nephrol Dial Transplant, 2015, 30(9):1542-1551
[21]Nagel C J, Casal M C, Lindley E, et al.Management of hyperphosphataemia: practices and perspectives amongst the renal care community[J].J Ren Care, 2014, 40(4):230-238
[22]Kalantar-Zadeh K.Patient education for phosphorus management in chronic kidney disease[J].Patient Prefer Adherence, 2013, 7:379-390
[23]Koiwa F, Terao A.Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized,placebo-controlled,double-blind,Phase II study[J].Clin Exp Nephrol, 2017, 21(3):513-522
